What is ASLN's current stock price?

ASLN (ASLAN Pharmaceuticals Limited) is currently trading at $0.60 with a market cap of $777.1M.

What sector is ASLAN Pharmaceuticals Limited in?

ASLAN Pharmaceuticals Limited (ASLN) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

ASLN ASLAN Pharmaceuticals Limited

NASDAQHealthcare

$0.6000-14.27%ClosedMarket Cap: $777.1M

As of 2024-07-18 16:00

Why ASLN matters now

ASLAN Pharmaceuticals Limited (ASLN) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.60 with -14.27% on the session and $777.1M in market capitalization.

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

1.40

ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.